Apatinib enhances the anti-tumor effect of paclitaxel via the PI3K/p65/Bcl-xl pathway in triple-negative breast cancer.

Ann Transl Med · 2021 · PMC8267319 · PMID 34277801

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Expression of p65 showed an increasing trend and Bcl-xl expression showed a declining trend.

also in 63,971 other papers

a decreasing trendno p-value reported

Expression of p-PI3K showed a decreasing trend.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.